Study warns of serious complications for type 2 diabetes patients
A US study of 1.6 million people found one-third of type 2 diabetes patients face heart failure, kidney disease, or death within five years of diagnosis.
Key Takeaways
AIA large-scale study has warned of serious complications that may affect people with type 2 diabetes within a short period. The results showed that about one-third of patients are at risk of heart failure, kidney disease, or death within five years of diagnosis, with the rate rising to over 55% within ten years.
Researchers from the University of Glasgow analyzed data from more than 1,600,000 people in the United States diagnosed with type 2 diabetes between 2010 and 2024. The average age of participants was 59, and the average body mass index was 31, which is classified as obese.
According to the study, as reported by the Daily Mail, one in five patients developed chronic kidney disease within the first five years after diagnosis. The likelihood of developing chronic kidney disease was 42% higher among those who had heart failure, while the risk of heart failure was 23% higher in those who first developed kidney disease.
Lead researcher Professor Naveed Sattar explained that obesity, high blood pressure, abnormal blood lipids, and elevated blood sugar damage blood vessels and vital organs. He stressed the importance of early diagnosis and comprehensive treatment to reduce risks.
Type 2 diabetes occurs when the body does not respond properly to insulin or does not produce enough of it, leading to high blood sugar. The disease's complications are linked to several types of cancer, with women facing a 22% higher risk of cancer compared to 12% for men.
Research into weight-loss drugs such as Wegovy and Mounjaro has increased, as these medications help reduce weight and control blood sugar levels. Studies indicate they may lower the risk of kidney disease by 24%.
The researchers emphasized that managing type 2 diabetes should include early screening, controlling risk factors, and regular monitoring of heart and kidney health, not just blood sugar management.
